Real Life Second-Line Nivolumab in Advanced Non-Small Cell Lung Cancer

Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy

NCT02910999 ·Status: COMPLETED

Accelerated Radio-Immunotherapy for Lung Cancer

NCT04577638 ·Status: COMPLETED ·Phase: PHASE2

Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%

NCT03808480 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)

NCT02411591 ·Status: COMPLETED ·Phase: PHASE1

Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program

NCT02933346 ·Status: COMPLETED

Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients

NCT03081689 ·Status: COMPLETED ·Phase: PHASE2

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

NCT04025879 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan

NCT03273790 ·Status: COMPLETED

Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient

NCT03132493 ·Status: COMPLETED

Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC Patients

NCT03351361 ·Status: COMPLETED ·Phase: PHASE3

A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC

NCT04023617 ·Status: UNKNOWN ·Phase: PHASE2

PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer

NCT03774732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

NCT03090737 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

NCT00651508 ·Status: COMPLETED ·Phase: PHASE2

Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients

NCT03509584 ·Status: TERMINATED ·Phase: PHASE1

SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects

NCT03383302 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%

NCT07215962 ·Status: ACTIVE_NOT_RECRUITING

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

NCT03158129 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of PEMbrolizumab PD-L1-positive (>50% of Tumor Cells), Advanced NSCL Cancer(PEMBREIZH)

NCT05321212 ·Status: COMPLETED

An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

NCT01333007 ·Status: COMPLETED

Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC

NCT02259621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)

NCT02595944 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients

NCT04205552 ·Status: RECRUITING ·Phase: PHASE2

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

NCT04026412 ·Status: COMPLETED ·Phase: PHASE3

Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer

NCT02581943 ·Status: COMPLETED ·Phase: PHASE2